文献速递前列腺癌

低危局限性前列腺癌主动监测与观察等待的长期心理与生活质量影响

Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.
PubMed 文献 · Eur Urol · 2017-08-26

基于澳大利亚新南威尔士州人群前瞻性队列,纳入诊断时<70岁且完成10年随访的低危局限性前列腺癌患者,评估初始主动监测/观察等待与积极治疗对长期心理及生活质量的影响。诊后9-11年,初始监测组在 distress、过度警觉、回避、尿失禁和肠道困扰方面与部分积极治疗组存在差异,但多数长期结局相似。

要点

  • 初始主动监测/观察等待组与初始放疗/高剂量率近距离治疗组相比,distress和过度警觉较高。
  • 初始主动监测/观察等待组与初始低剂量率近距离治疗组相比,distress和回避较高。
  • 初始主动监测/观察等待组尿失禁评分优于初始根治性前列腺切除术组,肠道困扰少于初始放疗/高剂量率近距离治疗组。

核心结论

  • 尽管主动监测/观察等待与各积极治疗组在distress、过度警觉、回避、尿失禁和肠道困扰方面存在一些长期差异,但多数长期结局在组间相似。

研究设计与样本

  • 前列腺癌照护与结局研究为澳大利亚新南威尔士州基于人群的前瞻性队列研究。
  • 分析纳入诊断时年龄<70岁且参与10年随访的低危局限性前列腺癌患者。

主要发现

  • 诊断后9-11年,初始主动监测/观察等待组distress高于初始放疗/高剂量率近距离治疗组(AMD=5.9;95%CI [0.5, 11.3])。
  • 诊断后9-11年,初始主动监测/观察等待组过度警觉高于初始放疗/高剂量率近距离治疗组(AMD=5.4;95%CI [0.2, 10.5])。
  • 诊断后9-11年,初始主动监测/观察等待组distress高于初始低剂量率近距离治疗组(AMD=5.3;95%CI [0.2, 10.3])。
  • 诊断后9-11年,初始主动监测/观察等待组回避高于初始低剂量率近距离治疗组(AMD=7.0;95%CI [0.5, 13.5])。
  • 诊断后9-11年,初始主动监测/观察等待组尿失禁评分优于初始根治性前列腺切除术组(AMD=-9.1;95%CI [-16.3, -2.0]),肠道困扰少于初始放疗/高剂量率近距离治疗组(AMD=-16.8;95%CI [-27.6, -6.0])。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 参与者失访。
  • 无法评估排尿和储尿症状。
  • 治疗分配非随机。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Long-term psychological well-being and quality-of-life are important considerations when deciding whether to undergo active treatment for low-risk localised prostate cancer. OBJECTIVE: To assess the long-term effects of active surveillance (AS) and/or watchful waiting (WW) on psychological and quality-of-life outcomes for low-risk localised prostate cancer patients. DESIGN, SETTING, AND PARTICIPANTS: The Prostate Cancer Care and Outcome Study is a population-based prospective cohort study in New South Wales, Australia. Participants for these analyses were low-risk localised prostate cancer patients aged <70 yr at diagnosis and participated in the 10-yr follow-up. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Validated instruments assessed outcomes relating to six health-related quality-of-life and nine psychological domains relevant to prostate cancer patients. Adjusted mean differences (AMDs) in outcome scores between prostate cancer treatment groups were estimated using linear regression. RESULTS AND LIMITATIONS: At 9-11 yr after diagnosis, patients who started AS/WW initially had (1) higher levels of distress and hyperarousal than initial radiation/high-dose-rate brachytherapy patients (AMD=5.9; 95% confidence interval or CI [0.5, 11.3] and AMD=5.4; 95% CI [0.2, 10.5], respectively), (2) higher levels of distress and avoidance than initial low-dose-rate brachytherapy patients (AMD=5.3; 95% CI [0.2, 10.3] and AMD=7.0; 95% CI [0.5, 13.5], respectively), (3) better urinary incontinence scores than initial radical prostatectomy patients (AMD=-9.1; 95% CI [-16.3, -2.0]), and (4) less bowel bother than initial radiation/high-dose-rate brachytherapy patients (AMD=-16.8; 95% CI [-27.6, -6.0]). No other significant differences were found. Limitations include participant attrition, inability to assess urinary voiding and storage symptoms, and nonrandom treatment allocation. CONCLUSIONS: Notwithstanding some long-term differences between AS/WW and various active treatment groups in terms of distress, hyperarousal, avoidance, urinary incontinence, and bowel bother, most long-term outcomes were similar between these groups. PATIENT SUMMARY: This study assessed the long-term psychological and quality-of-life impacts of initially monitoring rather than actively treating low-risk prostate cancer. The results suggest that initial monitoring rather than active treatment has only a minor impact on subsequent long-term psychological and quality-of-life outcomes.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Egger SJ, Calopedos RJ, O'Connell DL, et al. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer. Eur Urol. 2017. PMID: 28851582. doi:10.1016/j.eururo.2017.08.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。